Online study and academic help platform Chegg (NYSE:CHGG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 30.4% year on year to $121.4 million. On the other hand, next quarter’s revenue guidance of $101 million was less impressive, coming in 9.2% below analysts’ estimates. Its non-GAAP loss of $0.06 per share was significantly below analysts’ consensus estimates.
Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.2% year on year to $776 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $3.38 billion at the midpoint. Its non-GAAP profit of $0.04 per share was $0.01 below analysts’ consensus estimates.
Project management software maker Monday.com (NASDAQ:MNDY) announced better-than-expected revenue in Q1 CY2025, with sales up 30.1% year on year to $282.3 million. The company expects next quarter’s revenue to be around $293 million, close to analysts’ estimates. Its non-GAAP profit of $1.10 per share was 56.4% above analysts’ consensus estimates.
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.67 billion. The company’s full-year revenue guidance of $28.4 billion at the midpoint came in 1.1% below analysts’ estimates. Its non-GAAP profit of $1.81 per share was 2.1% above analysts’ consensus estimates.
Beauty supply retailer Sally Beauty (NYSE:SBH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 2.8% year on year to $883.1 million. On the other hand, the company expects next quarter’s revenue to be around $942.3 million, close to analysts’ estimates. Its non-GAAP profit of $0.42 per share was 6.6% above analysts’ consensus estimates.
With JD.com set to report earnings on May 13, you may not realize that the stock is also heading into one of its most statistically supportive seasonal windows.
3D measurement and imaging company FARO (NASDAQ:FARO) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $82.86 million. The company expects next quarter’s revenue to be around $83 million, close to analysts’ estimates. Its non-GAAP profit of $0.33 per share was significantly above analysts’ consensus estimates.
Medical technology company Integer Holdings (NYSE:ITGR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 7.3% year on year to $437.4 million. The company expects the full year’s revenue to be around $1.86 billion, close to analysts’ estimates. Its non-GAAP profit of $1.31 per share was 5.5% above analysts’ consensus estimates.
Clinical research company Fortrea Holdings (NASDAQ:FTRE) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $651.3 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.02 per share was significantly above analysts’ consensus estimates.
The US futures rose Monday as the US said “substantial progress” in trade talks with China after two days of negotiations in Switzerland over the weekend.
Aerospace and defense company Redwire (NYSE:RDW) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 30.1% year on year to $61.4 million. On the other hand, the company’s full-year revenue guidance of $570 million at the midpoint came in 32.2% above analysts’ estimates. Its GAAP loss of $0.09 per share was 76.3% above analysts’ consensus estimates.
ZIMMER BIOMET HOLDINGS INC has a stellar value proposition. NYSE:ZBH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point.
Freight transportation company Union Pacific (NYSE:UNP) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.03 billion. Its non-GAAP profit of $2.70 per share was 1.1% below analysts’ consensus estimates.
Vehicle manufacturer Shyft (NASDAQ:SHYF) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $204.6 million. The company’s full-year revenue guidance of $920 million at the midpoint came in 3.8% above analysts’ estimates. Its non-GAAP profit of $0.07 per share was significantly above analysts’ consensus estimates.
Theme park operator United Parks & Resorts (NYSE:PRKS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 3.5% year on year to $286.9 million. Its GAAP loss of $0.29 per share was 26.7% below analysts’ consensus estimates.
